{"name":"Associazione Italiana per lo Studio del Pancreas","slug":"associazione-italiana-per-lo-studio-del-pancreas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"PAXG","genericName":"PAXG","slug":"paxg","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"long-course chemotherapy","genericName":"long-course chemotherapy","slug":"long-course-chemotherapy","indication":"Treatment of various cancers","status":"phase_3"}]}],"pipeline":[{"name":"PAXG","genericName":"PAXG","slug":"paxg","phase":"phase_3","mechanism":"PAXG is a drug that targets the PD-1 receptor.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"long-course chemotherapy","genericName":"long-course chemotherapy","slug":"long-course-chemotherapy","phase":"phase_3","mechanism":"Long-course chemotherapy involves administering chemotherapy drugs over an extended period to target and kill cancer cells.","indications":["Treatment of various cancers"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNWFc2RUhmMzhYSm14VVgzMnBzNTdQaU1uYzE4WVJhU1NNVG1wVTBkTHJnczkyOVJiNU5DSUFUbmI1Ylk3aFhYZzVpUmJHUHI3dkIzVmZTZmVzSzF5MklTUjBsT0hOczFPQnlEb2dqcnRMNHVtX0x4MTFBbE5LT3poX3pfRkdFYzc3dWJxQ1h3eHdCN3hKajlRdnBrdDB2a2htUDR5NXE0THg0UUVtMUFnNEhVOVhueUhtSVVjRzlYazZXZw?oc=5","date":"2025-06-03","type":"pipeline","source":"Oncology News Central","summary":"Decades-Long Standard of Care in Head and Neck Cancer Set to Change? - Oncology News Central","headline":"Decades-Long Standard of Care in Head and Neck Cancer Set to Change?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9FSEV4QXlTSmVzTWxZY3VSbFhReElGcF9mc3lsTU85aU53V0gyZ2hIaS14bXcwMUpJc2RsXzE3S2NsX3A4b0hzSzRLUm5PblhjOUFlUW1zN1M1NWczQWxIckFQTlk2TlE?oc=5","date":"2025-06-02","type":"pipeline","source":"MedPage Today","summary":"New Preoperative Regimen Gets a Win in Pancreatic Cancer - MedPage Today","headline":"New Preoperative Regimen Gets a Win in Pancreatic Cancer","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}